UltraSight
AI cardiac ultrasound company
UltraSight has raised €11M across 1 funding round from 3 investors, most recently a Series B round in May 2021. Based in Israel; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€11M
€10,723,418
Funding rounds
1
Investors
3
distinct backers
Active since
2021-05
latest 2021-05
Funding by year
EUR raised per yearUltraSight — funding by year — interactive chart.
Data table
| UltraSight — funding by year | |
|---|---|
| 2021 | €11M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-05-14 | Series B | €11M | Atain Specialty Insurance,Weizmann Institute of Science,Yozma Group Korea | View deal → |
Related news
- Israeli AI cardiac ultrasound co UltraSight raises $13men.globes.co.il · 2021-05
Similar companies
same sector, similar size- Hagar€10.0MIsrael · Healthtech
- Belkin Laser€15MIsrael · Healthtech
- Nym€11MIsrael · Healthtech
- Radiaction€16MIsrael · Healthtech
- OrthoSpin€7.0MIsrael · Healthtech
- Uniper Care Technologies€12MIsrael · Healthtech
Global coverage: FundingData